MXPA03010467A - Produccion y uso de una fraccion polar rica en lipidos que contienen acido estearidonico y acido gama-linolenico proviniente de semillas y microbios. - Google Patents

Produccion y uso de una fraccion polar rica en lipidos que contienen acido estearidonico y acido gama-linolenico proviniente de semillas y microbios.

Info

Publication number
MXPA03010467A
MXPA03010467A MXPA03010467A MXPA03010467A MXPA03010467A MX PA03010467 A MXPA03010467 A MX PA03010467A MX PA03010467 A MXPA03010467 A MX PA03010467A MX PA03010467 A MXPA03010467 A MX PA03010467A MX PA03010467 A MXPA03010467 A MX PA03010467A
Authority
MX
Mexico
Prior art keywords
production
acid
microbes
polar lipid
gamma linolenic
Prior art date
Application number
MXPA03010467A
Other languages
English (en)
Spanish (es)
Inventor
Ruben Abril Jesus
Original Assignee
Martek Biosciences Boulder Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Martek Biosciences Boulder Corp filed Critical Martek Biosciences Boulder Corp
Publication of MXPA03010467A publication Critical patent/MXPA03010467A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • Animal Husbandry (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
MXPA03010467A 2001-05-14 2002-05-14 Produccion y uso de una fraccion polar rica en lipidos que contienen acido estearidonico y acido gama-linolenico proviniente de semillas y microbios. MXPA03010467A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29148401P 2001-05-14 2001-05-14
PCT/US2002/015479 WO2002092073A1 (en) 2001-05-14 2002-05-14 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes

Publications (1)

Publication Number Publication Date
MXPA03010467A true MXPA03010467A (es) 2004-12-06

Family

ID=23120484

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010467A MXPA03010467A (es) 2001-05-14 2002-05-14 Produccion y uso de una fraccion polar rica en lipidos que contienen acido estearidonico y acido gama-linolenico proviniente de semillas y microbios.

Country Status (7)

Country Link
US (1) US20070004678A1 (enExample)
EP (2) EP2275101A1 (enExample)
JP (2) JP4728561B2 (enExample)
AU (3) AU2002318135B2 (enExample)
CA (2) CA2689808A1 (enExample)
MX (1) MXPA03010467A (enExample)
WO (1) WO2002092073A1 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2255668A3 (en) * 2001-05-14 2012-04-04 Martek Biosciences Corporation Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms
JP4499371B2 (ja) * 2003-01-14 2010-07-07 株式会社 エフェクト 落花生由来のプロアントシアニジンの製造方法
JP4541662B2 (ja) * 2003-05-29 2010-09-08 オリザ油化株式会社 抗ピロリ菌組成物
AU2004268196B2 (en) 2003-08-21 2010-03-04 Monsanto Technology Llc Fatty acid desaturases from primula
JP4313632B2 (ja) * 2003-09-05 2009-08-12 ポーラ化成工業株式会社 食品組成物
MY140210A (en) * 2003-12-22 2009-11-30 Suntory Holdings Ltd Marchantiales-derived unsaturated fatty acid synthetase genes and use of the same
JP2007533310A (ja) 2004-04-16 2007-11-22 モンサント テクノロジー エルエルシー トウモロコシにおける脂肪酸デサチュラーゼの発現
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
EP2218334B1 (en) 2004-11-04 2016-09-28 Monsanto Technology LLC Processes for preparation of oil compositions
EP1965658B2 (en) * 2005-11-18 2022-10-05 Commonwealth Scientific and Industrial Research Organisation Feedstuffs for aquaculture comprising stearidonic acid feedstuffs for aquaculture
BR122018075948B1 (pt) 2006-03-10 2023-05-16 Monsanto Technology Llc Métodos de produzir uma planta de soja com teor de ácidos graxos de semente alterados
ATE508186T1 (de) * 2006-07-19 2011-05-15 Monsanto Technology Llc Fettsäuredesaturasen aus tetraselmis suecica
JP2010516230A (ja) 2007-01-03 2010-05-20 モンサント テクノロジー エルエルシー ステアリドン酸を取り込む食物組成物
US10449224B2 (en) 2007-05-25 2019-10-22 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex, methods of using and compositions thereof
US10045951B2 (en) * 2007-05-25 2018-08-14 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex and its use thereof
EP2178539A4 (en) * 2007-08-17 2011-05-04 Murray Goulburn Coop Co Ltd PHOSPHOLIPIDE COMPREHENSIVE COMPOSITIONS
NZ598199A (en) 2007-09-12 2013-12-20 Martek Biosciences Corp Biological oils and production and uses thereof
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
EP2211881A4 (en) * 2007-11-01 2012-01-04 Wake Forest University School Of Medicine COMPOSITIONS AND METHOD FOR THE PREVENTION AND TREATMENT OF SEDUCTIVES OF MAMMALS
WO2009073397A1 (en) * 2007-11-29 2009-06-11 Monsanto Technology Llc Meat products with increased levels of beneficial fatty acids
AR070320A1 (es) * 2008-01-29 2010-03-31 Monsanto Technology Llc Metodos para alimentar cerdos y productos que comprenden acidos grasos beneficos
US20090197955A1 (en) * 2008-01-31 2009-08-06 Monsanto Company Methods of improving dha deposition and related function and/or development
WO2009102558A2 (en) * 2008-02-11 2009-08-20 Monsanto Technology Llc Aquaculture feed, products, and methods comprising beneficial fatty acids
US20110237851A1 (en) * 2008-04-25 2011-09-29 Conocophillips Company Thermal cracking of impurities in triglyceride feedstock
GB0814105D0 (en) * 2008-08-01 2008-09-10 Springdale Sustainable Develop Composition for accelerated production of collagen
WO2010034742A1 (en) * 2008-09-25 2010-04-01 Biosystems International Sas Methods of detecting and treating pulmonary disease and markers thereof
JP2010079993A (ja) * 2008-09-26 2010-04-08 Toshiba Storage Device Corp 記憶装置および記憶装置の調整方法
WO2010088700A1 (en) 2009-02-02 2010-08-05 Martek Biosciences Corporation Methods for improving cognitive function and decreasing heart rate
GB0902040D0 (en) 2009-02-06 2009-03-11 Seeds Lp Composition for treatment of skin
CN102427733A (zh) * 2009-03-16 2012-04-25 孟山都技术公司 包含有益脂肪酸的家禽肉和蛋
US8323708B2 (en) * 2009-03-16 2012-12-04 Monsanto Technology Llc Poultry meat and eggs comprising beneficial fatty acids
EP2272383A1 (en) 2009-06-22 2011-01-12 SBAE Industries NV Composition Comprising Omega-7 and/or Omega-4 Fatty Acids
CN107087780A (zh) * 2009-06-30 2017-08-25 孟山都技术公司 富含ω‑3的坚果黄油及其相关产物
US20110177061A1 (en) 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid
US9480271B2 (en) 2009-09-15 2016-11-01 Monsanto Technology Llc Soybean seed and oil compositions and methods of making same
WO2011041710A2 (en) 2009-10-01 2011-04-07 Martek Biosciences Corporation Docosahexaenoic acid gel caps
SG185578A1 (en) 2010-06-14 2013-01-30 Io Mega Holding Corp Methods for the production of algae derived oils
US8563611B2 (en) * 2011-03-17 2013-10-22 Women's & Children's Health Research Institute Methods and compositions for promoting the respiratory development of an infant
WO2013024174A1 (en) 2011-08-18 2013-02-21 Dsm Ip Assets B.V. Dha triglyceride, dha free fatty acid, and dha ethyl ester emulsions, and methods of treating spinal cord injury
RU2619755C2 (ru) 2011-11-01 2017-05-18 ДСМ АйПи АССЕТС Б.В. Масла, содержащие полиненасыщенные жирные кислоты, устойчивые к окислению
KR101589825B1 (ko) * 2014-03-25 2016-02-01 고려대학교 산학협력단 에키움 오일로부터 농축된 스테아리돈산을 회수하는 방법
CN106302571B (zh) * 2015-05-14 2020-07-28 微软技术许可有限责任公司 用于对服务器连接进行维护和高速缓存的系统和方法
JP6885582B2 (ja) * 2017-02-23 2021-06-16 御木本製薬株式会社 トランスグルタミナーゼ活性促進剤
CN115569093B (zh) * 2022-09-09 2023-10-13 安徽亿人安股份有限公司 一种具有抗菌作用的婴儿祛湿护肤膏及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
GB8408974D0 (en) * 1984-04-06 1984-05-16 Efamol Ltd Food production
CH663951A5 (fr) * 1984-10-10 1988-01-29 Nestle Sa Procede d'enrichissement selectif en acides gras polyinsatures d'un melange contenant des acides gras fractions enrichies obtenues et compositions les contenant.
WO1986004354A1 (en) * 1985-01-22 1986-07-31 Japan As Represented By Director General Of Agency Method for obtaining lipids from fungus bodies
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
US4816271A (en) * 1987-01-16 1989-03-28 Adelia Scaffidi Skin lotions and creams
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
DK0457950T3 (da) * 1990-05-23 1994-03-07 Nestle Sa Anvendelse af stearidonsyre til behandling af inflammatorisk betingede sygdomme
GB9012651D0 (en) * 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
PH31293A (en) * 1991-10-10 1998-07-06 Rhone Poulenc Agrochimie Production of y-linolenic acid by a delta6-desaturage.
DE4219360C2 (de) * 1992-06-12 1994-07-28 Milupa Ag Verfahren zur Gewinnung von Lipiden mit einem hohen Anteil von langkettig-hochungesättigten Fettsäuren
GB9217781D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
EP0585058A1 (en) * 1992-08-25 1994-03-02 Scotia Holdings Plc Pharmaceutical compositions containing fatty acids and heparin
GB9423625D0 (en) * 1994-11-23 1995-01-11 Scotia Holdings Plc Fortified fruit juice
US5583019A (en) * 1995-01-24 1996-12-10 Omegatech Inc. Method for production of arachidonic acid
AU5346296A (en) * 1995-04-17 1996-11-07 Japan As Represented By Director-General Of Agency Of Industrial Science And Technology Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fa tty acids by using the microorganisms
SE504664C2 (sv) * 1995-09-22 1997-03-24 Scotia Lipidteknik Ab Sätt att framställa fraktionerad olja, oljan, dess användning samt emulsionskomposition innehållande oljan
US5883273A (en) * 1996-01-26 1999-03-16 Abbott Laboratories Polyunsaturated fatty acids and fatty acid esters free of sterols and phosphorus compounds
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
US5968809A (en) * 1997-04-11 1999-10-19 Abbot Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use
GB9715203D0 (en) * 1997-07-19 1997-09-24 Piper Edwina M Composition
DE19757414A1 (de) * 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
EP2255668A3 (en) * 2001-05-14 2012-04-04 Martek Biosciences Corporation Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms
EP1417211B1 (en) * 2001-07-27 2007-05-30 Neptune Technologies & Bioressources Inc. Natural phospholipids of marine origin containing flavonoids and polyunsaturated phospholipids and their uses

Also Published As

Publication number Publication date
JP4728561B2 (ja) 2011-07-20
CA2689808A1 (en) 2002-11-21
WO2002092073A1 (en) 2002-11-21
JP2004536801A (ja) 2004-12-09
EP1392278A4 (en) 2005-05-04
AU2007225606A1 (en) 2007-11-01
EP2275101A1 (en) 2011-01-19
CA2446059C (en) 2010-03-23
AU2009212905A1 (en) 2009-10-01
AU2007225606B2 (en) 2009-06-04
JP2010229144A (ja) 2010-10-14
CA2446059A1 (en) 2002-11-21
EP1392278A1 (en) 2004-03-03
AU2002318135B2 (en) 2007-08-02
US20070004678A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
MXPA03010467A (es) Produccion y uso de una fraccion polar rica en lipidos que contienen acido estearidonico y acido gama-linolenico proviniente de semillas y microbios.
GB2396026B (en) Integration of graphic display elements, process modules and control modules in process plants
MXPA01010488A (es) Secuencias de acidos nucleicos para proteinas que intervienen en sintesis isoprenoide.
EP3170410A3 (en) Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
WO2004071178A3 (en) Annexin and p34 promoters and use in expression of transgenic genes in plants
GB0420761D0 (en) Appliances for extracting juice and pulp from plant products with improved yields
UY26734A1 (es) Nuevos probióticos para aplicaciones de alimento de mascotas
WO2003056904A3 (en) Transgenic plants expressing civps or intein modified proteins and related method
MXPA06000092A (es) Transformacion de cloroplasto de la lenteja de agua.
FI19992659A7 (fi) Prosessi kaksisirkkaisten siementen varastoravintoaineiden muuttamiseksi yhden tai useamman geenituotteen sisältäviksi aineosiksi
WO2003101923A3 (en) Policosanol compositions, extraction from novel sources, and uses thereof
AU5354301A (en) Nucleic acid sequences to proteins involved in tocopherol synthesis
ATE433670T1 (de) Futtermittelzusammensetzung
WO2002033060A3 (en) Nucleic acid sequences to proteins involved in tocopherol synthesis
AU2003901693A0 (en) Direct smelting process and plant
PT1513824E (pt) Furanocarboxamidas
ZA200405376B (en) Granulated product and process to prepare the same.
PL373468A1 (en) Oxathiincarboxamides
MXPA05011209A (es) Sistema de distribucion de ingredientes basados en particulas.
AU2003208343A1 (en) Identification labels in plants or plant parts
WO2004023889A3 (en) Full range nutritional supplements from plant materials and methods for their manufacture
SE0103693L (sv) Zeoliter som matrix
AU2002349829A1 (en) Production process for plant biomass and its use
Gilmore Advances in understanding acclimation to light stress and light-energy dissipation mechanisms in photosynthetic organisms: an overview of the Light Stress and Photosynthesis meeting (LS2001) and dedicated Special Section papers
AU2003267064A1 (en) Contact lens care product containing natural plant extracts

Legal Events

Date Code Title Description
FG Grant or registration